Filing Details
- Accession Number:
- 0001628280-24-025894
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-30 17:45:16
- Reporting Period:
- 2024-05-28
- Accepted Time:
- 2024-05-30 17:45:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1870278 | Alexander Michael Smith | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-28 | 7,000 | $16.07 | 101,579 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 10,000 | $16.16 | 111,579 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,691 | $10.85 | 115,270 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 3,470 | $11.38 | 118,740 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-05-28 | 14,810 | $13.67 | 133,550 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-28 | 44,722 | $49.53 | 88,828 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 7,000 | $0.00 | 7,000 | $16.07 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 10,000 | $0.00 | 10,000 | $16.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,691 | $0.00 | 3,691 | $10.85 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 3,470 | $0.00 | 3,470 | $11.38 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-05-28 | 14,810 | $0.00 | 14,810 | $13.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-01-08 | No | 4 | M | Direct | |
| 0 | 2026-01-07 | No | 4 | M | Direct | |
| 0 | 2026-05-19 | No | 4 | M | Direct | |
| 0 | 2026-08-02 | No | 4 | M | Direct | |
| 0 | 2027-01-05 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Billionaire Hedge Funds
